Zobit OZ 50mg/125mg Oral Suspension
34,00 ₹
Analogs of Zobit OZ 50mg/125mg Oral Suspension
Find cheaper analogs and generic equivalents for Zobit OZ 50mg/125mg Oral Suspension.
Active Ingredient: Ofloxacin; Ornidazole
Product Overview
About Zobit OZ
Zobit OZ is a medication containing the active ingredient Ofloxacin, classified as Antibiotic to treat bacterial infections. Ofloxacin, sold under the brand name Floxin among others, is a quinolone antibiotic useful for the treatment of a number of bacterial infections. When taken by mouth or injection into a vein, these include pneumonia, cellulitis, urinary tract infections, prostatitis, plague, and certain types of infectious diarrhea.
Key Benefits & Uses
- Used for: INDICATIONS AND USAGE Ofloxacin Otic Solution 0
- Used for: 3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed.
- Use only as directed on the product label or by a healthcare professional.
Active Ingredient & Action
Ofloxacin, the active ingredient in Zobit OZ, belongs to the Antibiotic to treat bacterial infections class. INDICATIONS AND USAGE Ofloxacin Otic Solution 0. 3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: Otitis Externa in adults and pediatric patients, 6 months and older, due to Escherichia coli , Pseudomonas aeruginosa…. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking Zobit OZ. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Zobit OZ for extended periods without medical advice.
Find in Pharmacies
Compare local prices and distance for Zobit OZ 50mg/125mg Oral Suspension.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.